SEC Form 4 · accession 0001209191-18-047122
EMMAUS LIFE SCIENCES, INC. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kurt H Kruger
Officer — Chief Financial Officer
Period of report
Aug 16, 2018
Accepted (ET)
Aug 16, 2018 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420031
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $11.30 | Aug 16, 2018 | A | 50,000 | A | — | Aug 16, 2028 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options will vest one-third (1/3) on the first anniversary of the grant date thereof, and thereafter will vest monthly in equal amounts (or as close to an equal amount as possible) until the third anniversary of the Grant Date.